Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Sue D. Pedersen"'
Autor:
Josephine Ho MD, Sue D. Pedersen MD, Heidi Virtanen BSc, Alberto Nettel-Aguirre PhD, Carol Huang MD, PhD
Publikováno v:
Global Pediatric Health, Vol 3 (2016)
Nutritional counseling for children with obesity is an important component of management. This randomized controlled trial was conducted to compare change in body mass index (BMI) z score after 6 months. Children 8 to 16 years with a BMI greater than
Externí odkaz:
https://doaj.org/article/8a760b823caa4523a49ad3f394ef20b0
Publikováno v:
Journal of Nutritional Science, Vol 5 (2016)
A preoperative weight loss of 8 % is a prerequisite to undergo bariatric surgery (BS) in Denmark. The aim of the present study was to evaluate the efficacy of a 7- or an 11-week low-energy diet (LCD) for achieving preoperative target weight before BS
Externí odkaz:
https://doaj.org/article/56bd7f618f5d426b882bacc1abdcff7e
Autor:
Sue D. Pedersen, Francesco Giorgino, Guillermo Umpierrez, Vivian T. Thieu, Angel Rodríguez, Claudia Nicolay, Laura Fernández Landó, Chrisanthi A. Karanikas, Jacek Kiljanski
Publikováno v:
Diabetes, Obesity and Metabolism.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6076ec503b5f7765d1e84ee0030e9bd0
https://doi.org/10.1111/dom.15140
https://doi.org/10.1111/dom.15140
Autor:
Sue D. Pedersen, Ronald Goldenberg, Amir A. Mohseni, Calum S. Neish, Carl Fournier, Susie Jin, Michael Vallis, Atif Kukaswadia, Andrean Bunko, Noah Ivers, Paulina K. Wrzal, Debbie Hollahan, Varun Myageri
Publikováno v:
Canadian Journal of Diabetes. 46:171-180
Therapeutic inertia in type 2 diabetes (T2DM) is the failure to receive timely treatment intensification as indicated per T2DM treatment guidelines. Multifactorial causes of therapeutic inertia in T2DM have been documented at the level of persons wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0585ee684bec9064454496fdb035aa10
https://doi.org/10.1016/j.jcjd.2021.08.004
https://doi.org/10.1016/j.jcjd.2021.08.004
Publikováno v:
Current Opinion in Cardiology. 36:661-671
Purpose of review Elevated levels of triglycerides, independent of low-density lipoprotein cholesterol (LDL-C) levels and statin therapy, are associated with heightened cardiovascular risk. Recent findings Mixed omega-3 fatty acid formulations, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbb8701f559d35a46c231087e3f96ccd
https://doi.org/10.1097/hco.0000000000000873
https://doi.org/10.1097/hco.0000000000000873
Autor:
Ildiko Lingvay, Sean Wharton, Ofri Mosenzon, Melanie J. Davies, Domenica Rubino, Dror Dicker, Sue D. Pedersen
Publikováno v:
Postgraduate medicine. 134(1)
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are well established in clinical practice for the treatment of type 2 diabetes, and are approved and recommended for weight management in overweight or obesity. Gastrointestinal side effects are we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e52f2421899104fefa2c1a806ed416
https://pubmed.ncbi.nlm.nih.gov/34775881
https://pubmed.ncbi.nlm.nih.gov/34775881
Autor:
Iichiro Shimomura, Ole K. Jeppesen, Adie Viljoen, Louise Færch, Arash Pakseresht, Ildiko Lingvay, Sue D. Pedersen, Leigh Perreault, Melanie J. Davies, René Gollan, Julio Rosenstock, Thomas A. Wadden
Publikováno v:
Adipositas-Kongress 2021 – 37. Jahrestagung der Deutschen Adipositas-Gesellschaft e.V..
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f573cc71b5ce8f12da85da3d6c95853f
https://doi.org/10.1055/s-0041-1735690
https://doi.org/10.1055/s-0041-1735690
Autor:
Ildiko Lingvay, Melanie J. Davies, Dror Dicker, Ofri Mosenzon, Mette Thomsen, Thomas A. Wadden, Bryan Goldman, Sue D. Pedersen, Domenica Rubino, Salvatore Calanna, Sean Wharton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abb435fb4d15a1accf85ea4743d469a3
https://doi.org/10.1111/dom.14551/v2/response1
https://doi.org/10.1111/dom.14551/v2/response1
Autor:
Dror Dicker, Ofri Mosenzon, Mette Thomsen, Ildiko Lingvay, Sue D. Pedersen, Salvatore Calanna, Thomas A. Wadden, Bryan Goldman, Melanie J. Davies, Sean Wharton, Domenica Rubino
Publikováno v:
Diabetes, obesitymetabolism. 24(1)
AIM We evaluated gastrointestinal (GI) adverse events (AEs) with once-weekly semaglutide 2.4 mg in adults with overweight or obesity and their contribution to weight loss (WL). MATERIALS AND METHODS AE analyses pooled data from the Semaglutide Treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317cc5a3111ca221bf1d6c68d4ceb8a1
https://pubmed.ncbi.nlm.nih.gov/34514682
https://pubmed.ncbi.nlm.nih.gov/34514682
Autor:
Henrik H. Meincke, Niels Zeuthen, Tugce Kalayci Oral, Robert F. Kushner, Domenica Rubino, Sean Wharton, Sue D. Pedersen, Donna H. Ryan, Ronette L. Kolotkin
Publikováno v:
Diabetes. 70
An analysis of the STEP 2 trial evaluated the effect of s.c. semaglutide 2.4 mg vs. placebo (PBO) on physical function (PF) in adults with overweight/obesity and type 2 diabetes (T2D). The STEP 2 trial was an RCT in adults with BMI ≥27 kg/m2 and T2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc44a3b352534b7c718c5e4b3edfcb26
https://doi.org/10.2337/db21-85-or
https://doi.org/10.2337/db21-85-or